insights_auto
Why is 4559 down 2.72%?
Dive Deeperchevron_right
4559:TYO
Zeria Pharmaceutical Co Ltd
¥1,898.00
arrow_downward
-2.72%(-53.00) 1D
Oct 2, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
¥1,938
High
¥1,938
Low
¥1,895
Mkt. cap
95.13B
Avg. vol.
162.22K
Volume
240.70K
Dividend
2.58%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.17
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
Open
¥1,938
High
¥1,938
Low
¥1,895
Mkt. cap
95.13B
Avg. vol.
162.22K
Volume
240.70K
Dividend
2.58%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.17
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
News stories
From web sources and news partners
marketscreener.com
·
32 minutes ago
Dow's laggard, Nike disappoints again with sales and guidance
FXEmpire
·
19 minutes ago
Nasdaq Index: Record High as Weak Payrolls Cut Rate-Hike Bets and Yields Fall
24/7 Wall St.
·
52 minutes ago
S&P 500 at 7,718 Midday: Tech Takes the Lead With Nasdaq Up 1.1%
ChartMill
·
2 hours ago
These S&P500 stocks are gapping in today's session
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp